Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D08TPS
|
||||
| Former ID |
DNAP001521
|
||||
| Drug Name |
Epidermal growth factor
|
||||
| Synonyms |
Gentel (TN)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Vulnerary [ICD10:S00-T98] | Approved | [551871] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C257H381N73O83S7
|
||||
| Canonical SMILES |
CCC(C)C(C(=O)NC(CCC(=O)O)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O<br />)NC(CC(=O)O)C(=O)NC(CO)C(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC(<br />C(C)O)C(=O)NC(CS)C(=O)NC(CC(=O)N)C(=O)NC(CS)C(=O)NC(C(C<br />)C)C(=O)NC(C(C)CC)C(=O)NCC(=O)NC(CC2=CC=C(C=C2)O)C(=O)N<br />C(CO)C(=O)NCC(=O)NC(CC(=O)O)C(=O)NC(CCCNC(=N)N)C(=O)NC(<br />CS)C(=O)NC(CCC(=O)N)C(=O)NC(C(C)O)C(=O)NC(CCCNC(=N)N)C(<br />=O)NC(CC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)NC<br />(CC3=CNC4=CC=CC=C43)C(=O)NC(CC5=CNC6=CC=CC=C65)C(=O)NC(<br />CCC(=O)O)C(=O)NC(CC(C)C)C(=O)NC(CCCNC(=N)N)C(=O)O)NC(=O<br />)C(CC7=CN=CN7)NC(=O)C(CCSC)NC(=O)C(CS)NC(=O)C(C(C)C)NC(<br />=O)CNC(=O)CNC(=O)C(CC(=O)N)NC(=O)C(CC(C)C)NC(=O)C(CS)NC<br />(=O)C(CC8=CC=C(C=C8)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(CC<br />9=CC=C(C=C9)O)NC(=O)C(CO)NC(=O)C(CO)NC(=O)C1CCCN1C(=O)C<br />(CS)NC(=O)CNC(=O)C1CCCN1C(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(<br />CO)NC(=O)C(CC(=O)N)N
|
||||
| InChI |
1S/C257H381N73O83S7/c1-20-123(15)203(245(404)283-103-192(351)285-157(80-127-42-52-135(339)53-43-127)222(381)313-171(104-331)210(369)281-101-191(350)287-167(92-198(360)361)228(387)290-146(37-27-70-273-255(265)266)213(372)318-177(110-414)238(397)292-148(62-65-185(259)344)217(376)327-205(125(17)337)249(408)294-147(38-28-71-274-256(267)268)212(371)309-168(93-199(362)363)229(388)298-153(76-117(3)4)218(377)289-145(36-26-69-272-254(263)264)211(370)303-162(86-133-96-277-144-35-25-23-33-141(133)144)226(385)304-161(85-132-95-276-143-34-24-22-32-140(132)143)225(384)291-149(63-66-195(354)355)214(373)297-154(77-118(5)6)219(378)296-152(253(412)413)39-29-72-275-257(269)270)326-247(406)202(122(13)14)324-242(401)181(114-418)320-227(386)165(90-188(262)347)307-241(400)180(113-417)322-250(409)206(126(18)338)328-231(390)160(83-130-48-58-138(342)59-49-130)302-234(393)174(107-334)315-230(389)169(94-200(364)365)310-221(380)155(78-119(7)8)299-233(392)173(106-333)314-215(374)150(64-67-196(356)357)295-248(407)204(124(16)21-2)325-232(391)163(87-134-97-271-116-284-134)305-216(375)151(68-75-420-19)293-239(398)179(112-416)321-246(405)201(121(11)12)323-194(353)99-278-189(348)98-279-208(367)164(89-187(261)346)306-220(379)156(79-120(9)10)300-240(399)178(111-415)319-223(382)158(81-128-44-54-136(340)55-45-128)286-190(349)100-280-209(368)166(91-197(358)359)308-224(383)159(82-129-46-56-137(341)57-47-129)301-235(394)175(108-335)316-237(396)176(109-336)317-244(403)184-41-31-74-330(184)252(411)182(115-419)288-193(352)102-282-243(402)183-40-30-73-329(183)251(410)170(84-131-50-60-139(343)61-51-131)311-236(395)172(105-332)312-207(366)142(258)88-186(260)345/h22-25,32-35,42-61,95-97,116-126,142,145-184,201-206,276-277,331-343,414-419H,20-21,26-31,36-41,62-94,98-115,258H2,1-19H3,(H2,259,344)(H2,260,345)(H2,261,346)(H2,262,347)(H,271,284)(H,278,348)(H,279,367)(H,280,368)(H,281,369)(H,282,402)(H,283,404)(H,285,351)(H,286,349)(H,287,350)(H,288,352)(H,289,377)(H,290,387)(H,291,384)(H,292,397)(H,293,398)(H,294,408)(H,295,407)(H,296,378)(H,297,373)(H,298,388)(H,299,392)(H,300,399)(H,301,394)(H,302,393)(H,303,370)(H,304,385)(H,305,375)(H,306,379)(H,307,400)(H,308,383)(H,309,371)(H,310,380)(H,311,395)(H,312,366)(H,313,381)(H,314,374)(H,315,389)(H,316,396)(H,317,403)(H,318,372)(H,319,382)(H,320,386)(H,321,405)(H,322,409)(H,323,353)(H,324,401)(H,325,391)(H,326,406)(H,327,376)(H,328,390)(H,354,355)(H,356,357)(H,358,359)(H,360,361)(H,362,363)(H,364,365)(H,412,413)(H4,263,264,272)(H4,265,266,273)(H4,267,268,274)(H4,269,270,275)/t123-,124-,125+,126+,142-,145-,146-,147-,148-,149-,150-,151-,152-,153-,154-,155-,156-,157-,158-,159-,160-,161-,162-,163-,164-,165-,166-,167-,168-,169-,170-,171-,172-,173-,174-,175-,176-,177-,178-,179-,180-,181-,182-,183-,184-,201-,202-,203-,204-,205-,206-/m0/s1
|
||||
| InChIKey |
VBEQCZHXXJYVRD-GACYYNSASA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Epidermal growth factor receptor | Target Info | Modulator | [543485] | |
| KEGG Pathway | MAPK signaling pathway | ||||
| ErbB signaling pathway | |||||
| Ras signaling pathway | |||||
| Rap1 signaling pathway | |||||
| Calcium signaling pathway | |||||
| Cytokine-cytokine receptor interaction | |||||
| HIF-1 signaling pathway | |||||
| FoxO signaling pathway | |||||
| Endocytosis | |||||
| PI3K-Akt signaling pathway | |||||
| Dorso-ventral axis formation | |||||
| Focal adhesion | |||||
| Adherens junction | |||||
| Gap junction | |||||
| Regulation of actin cytoskeleton | |||||
| GnRH signaling pathway | |||||
| Estrogen signaling pathway | |||||
| Oxytocin signaling pathway | |||||
| Epithelial cell signaling in Helicobacter pylori infection | |||||
| Hepatitis C | |||||
| Pathways in cancer | |||||
| Proteoglycans in cancer | |||||
| MicroRNAs in cancer | |||||
| Pancreatic cancer | |||||
| Endometrial cancer | |||||
| Glioma | |||||
| Prostate cancer | |||||
| Melanoma | |||||
| Bladder cancer | |||||
| Non-small cell lung cancer | |||||
| Central carbon metabolism in cancer | |||||
| Choline metabolism in cancer | |||||
| NetPath Pathway | IL4 Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| PANTHER Pathway | Cadherin signaling pathway | ||||
| EGF receptor signaling pathway | |||||
| Pathway Interaction Database | LPA receptor mediated events | ||||
| Signaling events mediated by PTP1B | |||||
| Arf6 signaling events | |||||
| Signaling events mediated by TCPTP | |||||
| Thromboxane A2 receptor signaling | |||||
| SHP2 signaling | |||||
| Regulation of Telomerase | |||||
| EGF receptor (ErbB1) signaling pathway | |||||
| EGFR-dependent Endothelin signaling events | |||||
| Posttranslational regulation of adherens junction stability and dissassembly | |||||
| Direct p53 effectors | |||||
| ErbB1 downstream signaling | |||||
| Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | |||||
| E-cadherin signaling in keratinocytes | |||||
| ErbB receptor signaling network | |||||
| Internalization of ErbB1 | |||||
| Stabilization and expansion of the E-cadherin adherens junction | |||||
| a6b1 and a6b4 Integrin signaling | |||||
| Syndecan-3-mediated signaling events | |||||
| Reactome | Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | ||||
| SHC1 events in ERBB2 signaling | |||||
| PLCG1 events in ERBB2 signaling | |||||
| PIP3 activates AKT signaling | |||||
| GRB2 events in EGFR signaling | |||||
| GAB1 signalosome | |||||
| SHC1 events in EGFR signaling | |||||
| EGFR downregulation | |||||
| GRB2 events in ERBB2 signaling | |||||
| PI3K events in ERBB2 signaling | |||||
| EGFR Transactivation by Gastrin | |||||
| Constitutive Signaling by Aberrant PI3K in Cancer | |||||
| Constitutive Signaling by EGFRvIII | |||||
| RAF/MAP kinase cascade | |||||
| WikiPathways | ErbB Signaling Pathway | ||||
| Regulation of Actin Cytoskeleton | |||||
| EGF/EGFR Signaling Pathway | |||||
| MAPK Signaling Pathway | |||||
| Focal Adhesion | |||||
| Aryl Hydrocarbon Receptor Pathway | |||||
| Extracellular vesicle-mediated signaling in recipient cells | |||||
| TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer | |||||
| Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||||
| Bladder Cancer | |||||
| Hair Follicle Development: Induction (Part 1 of 3) | |||||
| Signaling by ERBB4 | |||||
| Signaling by ERBB2 | |||||
| Gastrin-CREB signalling pathway via PKC and MAPK | |||||
| PIP3 activates AKT signaling | |||||
| Nanoparticle-mediated activation of receptor signaling | |||||
| Aryl Hydrocarbon Receptor | |||||
| Spinal Cord Injury | |||||
| Integrated Pancreatic Cancer Pathway | |||||
| Gastric cancer network 2 | |||||
| AGE/RAGE pathway | |||||
| Signaling Pathways in Glioblastoma | |||||
| Arylhydrocarbon receptor (AhR) signaling pathway | |||||
| miR-targeted genes in muscle cell - TarBase | |||||
| miR-targeted genes in lymphocytes - TarBase | |||||
| miR-targeted genes in epithelium - TarBase | |||||
| Integrated Breast Cancer Pathway | |||||
| Signaling by EGFR | |||||
| L1CAM interactions | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.